Skip to content

Prevention Trial to Achieve Cardiovascular Targets

Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01642355
Acronym
IMPACT
Enrollment
400
Registered
2012-07-17
Start date
2012-06-30
Completion date
2016-05-31
Last updated
2017-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Diabetes, Hyperlipidemia, Hypertension, Obesity, Peripheral Arterial Disease, Prediabetes

Brief summary

The objective of IMPACT (Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets) is to determine the best management strategy for patients undergoing cardiovascular intervention. IMPACT is a prospective randomized trial that will enroll 400 patients post-cardiovascular intervention. The study will compare different cardiovascular prevention strategies: (1) usual care, (2) cardiovascular prevention consult, and (3) cardiovascular prevention consult with a behavioral intervention program over a 6-month period. The trial hypothesis is that for patients undergoing a cardiovascular intervention, a prevention consult and behavioral intervention is superior to usual care in reducing cardiovascular risk. The primary endpoint will be non-HDL cholesterol. Secondary endpoints include other lipid values, metabolic risk, smoking cessation, physical activity, nutritional status, medication adherence and quality of life. IMPACT is scheduled to begin enrollment in the June of 2012.

Detailed description

SPECIFIC AIMS Primary aim: The primary aim is that a targeted Cardiovascular Prevention consult will reduce non-HDL cholesterol compared to usual care at 6 months post-intervention. Secondary aim: The secondary aim is that a targeted Cardiovascular Prevention consult plus a behavioral intervention will reduce non-HDL cholesterol compared to usual care at 6 months post-intervention.

Interventions

BEHAVIORALPrevention Consult

In addition to usual care, patients will receive a prevention consult by a prevention fellow and attending following their intervention. The consult will include guideline based medical recommendations for optimization of the patient's medical regimen targeting dyslipidemia, hypertension and diabetes. In addition, each patient will be educated on the cardiovascular disease process and given detailed lifestyle recommendations on physical activity, improved nutrition, smoking cessation and medication adherence.

BEHAVIORALConsult & Behavioral Intervention

In addition to usual care and prevention consult (as detailed above), patients will receive a full motivational intervention program by a trained motivational coach and text messages over 6 months.

Sponsors

The Rainer Arnhold Foundation
CollaboratorUNKNOWN
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* at least 21 years of age or older * Subjects scheduled to undergo a percutaneous coronary or peripheral vascular intervention * Patients must have the ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

* Life expectancy less than 1-year * Inability to walk

Design outcomes

Primary

MeasureTime frame
Reduction of Non-HDL cholesterol6 months

Secondary

MeasureTime frameDescription
Metabolic risk factors6 monthsweight, BMI, HbA1C, abdominal circumference
Physical Activity6 monthsYale Physical Activity assessment (Part 2)
Nutrition6 monthsNorthwest Lipid Research Clinic (NWLRC) Fat Intake Score and fruit and vegetable assessment questions
Medication Adherence6 monthsMorisky-4 medication adherence survey
Lipids6 monthsLDL-C, HDL, triglycerides
Quality of life6 monthsEuro Qual 5D survey
Smoking cessation6 monthsPatient-based Assessment and Counseling for Physical Activity and Nutrition (PACE) smoking assessment
Cardiovascular risk6 monthscardiovascular risk assessment score (i.e. Framingham)
Cardiovascular events5 yearscardiovascular events and hospitalizations reported by phone call follow-up up to 5 years
Optimal medical regimen6 monthsassessment of lipid lowering and cardiovascular medication regimen

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026